Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors.
Yang, B., Vasbinder, M.M., Hird, A.W., Su, Q., Wang, H., Yu, Y., Toader, D., Lyne, P.D., Read, J.A., Breed, J., Ioannidis, S., Deng, C., Grondine, M., DeGrace, N., Whitston, D., Brassil, P., Janetka, J.W.(2018) J Med Chem 61: 1061-1073
- PubMed: 29301085 
- DOI: 10.1021/acs.jmedchem.7b01490
- Primary Citation of Related Structures:  
6FC8, 6FCF, 6FCK - PubMed Abstract: 
Checkpoint kinase 1 (CHK1) inhibitors are potential cancer therapeutics that can be utilized for enhancing the efficacy of DNA damaging agents. Multiple small molecule CHK1 inhibitors from different chemical scaffolds have been developed and evaluated in clinical trials in combination with chemotherapeutics and radiation treatment ...